Differential expression of plasma proteins in cyclosporine A-induced rat acute nephrotoxicity

Bioscience, Biotechnology and Biochemistry

Volumn 73, Issue 3, 2009, Pages 592-598

  Shu, Zhan ^a   Pu, Xiaoping ^b   Xiong, Xin ^a,c   Li, Quan ^b   Wang, Yue ^a   Zhai, Suodi ^a,c  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c PEKING UNIVERSITY   (China)

Author keywords

Acute nephrotoxicity; Cyclosporine A; Rat plasma; Two dimensional gel electrophoresis

Indexed keywords

ACUTE NEPHROTOXICITY; CLINICAL APPLICATIONS; CLUSTERIN; CONTROL GROUPS; CYCLOSPORINE A; DIFFERENTIAL EXPRESSIONS; DISTILLED WATERS; HIGH DOSE; IMMUNOSUPPRESSIVE AGENTS; LOW DOSE; MALDI-TOF MS; PLASMA PROTEINS; RAT PLASMA; RENAL FUNCTIONS; TWO DIMENSIONAL GEL ELECTROPHORESIS; WISTAR RATS;

GELATION; GELS; GLYCOPROTEINS; PLASMA (HUMAN); PLASMAS; PROTEINS; RATS; TWO DIMENSIONAL;

ELECTROPHORESIS;

CYCLOSPORIN; PLASMA PROTEIN;

ANIMAL; ARTICLE; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; KIDNEY; MALE; MASS SPECTROMETRY; METABOLISM; PATHOLOGY; PROTEOMICS; RAT; TWO DIMENSIONAL GEL ELECTROPHORESIS; WISTAR RAT;

ANIMALS; BLOOD PROTEINS; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION REGULATION; KIDNEY; MALE; MASS SPECTROMETRY; PROTEOMICS; RATS; RATS, WISTAR;

RATTUS; RATTUS NORVEGICUS;

EID: 65349141909     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.80677     Document Type: Article

References (45)

1. Turk, G., Ateşşahin, A., Sönmez, M., Yüce, A., and Çeribaşi, A. O., Lycopene protects against cyclosporine A-induced testicular toxicity in rats. Theriogenology, 67, 778-785 (2007).
2. Falck, P., Guldseth, H., Asberg, A., Midtvedt, K., and Reubsaet, J. L. E., Determination of cyclosporin A and its six main metabolites in isolated T-lymphocytes and whole blood using liquid chromatography-tandem mass spectrometry. J. Chroma-togr. B, 852, 345-352 (2007).
3. Bertelli, A., Giovannini, L., Palla, R., Migliori, M., Panichi, V., and Andreini, B., Protective effect of L-propionylcarnitine on cyclosporine-induced nephrotoxicity. Drug Exp. Clin. Res., 21, 221-228 (1995).
4. Atasoyu, E. M., Yildiz, S., Cimsit, M., Cermik, H., Qyrdedi, T., Evrenkaya, T. R., Aktas, S., Uzun, G, Bilgi, O., and Gultepe, M., Investigation of the effect of hyperbaric oxygen on experimental cyclosporine nephrotoxicity. Basic Clin. Pharmacol. Toxicol, 98, 150-154 (2006).
5. Rezzani, R., Cyclosporine A and adverse effects on organs: histochemical studies. Prog. Histochem. Cytochem., 39, 85-128 (2004).
6. Calne, R. Y., Immunological tolerance: the liver effect. J. Gastroenterol. Hepatol. Rev., 17, 488-490 (2002).
7. Gauthier, P., and Helderman, H., Cyclosporine avoidance. J. Am. Soc. NephroL, 11, 1933-1936 (2000).
8. Mahalati, K., Belitsky, P., West, K., Kiberd, B., Fraser, A., Sketris, I., Macdonald, A. S., McAlister, V., and Lawen, J., Approaching the therapeutic window for cyclosporine in kidney transplantation: a prospective study. J. Am. Soc. NephroL, 12, 828-833 (2001).
9. Mahalati, K., Lawen, J., Kiberd, B., and Belitsky, P., Is 3-hour cyclosporine blood level superior to through level in early post-renal transplantation period? J. Urol., 163, 37-4-1 (2000).
10. Kennedy, S., Proteomics profiling from human samples: the body fluid alternative. Toxicol. Lett, 120, 379-384 (2001).
11. Bandara, L. R., Kelly, M. D., Lock, E. A., and Kennedy, S., A potential biomarker of kidney damage identified by proteomics: preliminary findings. Biomarkers, 8, 272-286 (2003).
12. Steiner, S., Aicher, L., Raymackers, J., Meheus, L., Esquer-Blasco, R., Anderson, N. L., and Cordier, A., Cyclosporine a decreases the protein level of the calcium-binding protein calbindin-D 28kDa in rat kidney. Biochem. Pharmacol., 51, 253-258 (1996).
13. Charlwood, J., Skehel, M., King, N., Camilleri, P., Lord, P., Bugelski, P., and Atif, U., Proteomic analysis of rat kidney cortex following treatment with gentamicin. J. Proteome Res., 1, 73-82 (2002).
14. Kennedy, S., The role of proteomics in toxicology: identification of biomarkers of toxicity by protein expression analysis. Biomarkers, 7, 1-22 (2002).
15. Petricoin, E. F., Ardekani, A. M., and Hitt, B. A., Use of proteomic patterns in serum to identify ovarian cancer. Lancet, 359, 572-577 (2002).
16. Kennedy, S., The role of proteomics in toxicology: identification of biomarkers of toxicity. Toxicol. Sci., 73, 195-206 (2003).
17. Son, W. K., Lee, D. Y., Lee, S. H., Joo, W. A., and Kim, C. W., Analysis of proteins expressed in rat plasma exposed to dioxin using 2-dimensional gel electrophoresis. Proteomics, 3, 2393-2401 (2003).
18. Lee, H. J., Lee, D. Y., Joo, W. A., Sui, D., Lee, E., and Kim, C. W., Differential expression of proteins in rat plasma exposed to benzene. Proteomics, 4, 3498-3504 (2004).
19. Piubelli, C, Cecconi, D., Astner, H., Caldara, F., Tessari, M., Carboni, L., Hamdan, M., Righetti, P. G., and Domenici, E., Proteomic changes in rat serum, polymorphonuclear and mononuclear leukocytes after chronic nicotine administration. Proteomics, 5, 1382-1394 (2005).
20. Sickmann, A., Dormeyer, W., Wortelkamp, S., Woitalla, D., Kuhn, W., and Meyer, H., Identification of proteins from human cerebrospinal fluid, separated by two-dimensional polyacryl-amide gel electrophoresis. Electrophoresis, 21, 2721-2728 (2000).
21. Neuhoff, V., Arold, N., Taube, D., and Ehrhard, W., Improved staining of proteins in polyacrylamide gels including isoelectric-focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis, 9, 255-262 (1988).
22. Dieperink, H., Starklint, H., and Leyssac, P. P., Nephrotoxicity of cyclosporine: an animal model. A study of the nephrotoxic effect of cyclosporine on overall renal and tubular function in conscious rats. Transplant. Proc, 15, 520-525 (1983).
23. English, J., Evan, A., Houghton, D. C, and Bennett, W. M., Cyclosporine-induced acute renal dysfunction in the rat. Transplantation, 44, 135-141 (1987).
24. Prévot, A., Semama, D. S., Justrabo, E., Guignard, J. P., Escousse, A., and Gouyon, J. B., Acute cyclosporine A-induced nephrotoxicity: a rabbit model. Pediatr. NephroL, 14, 370-375 (2000).
25. Gianazza, E., and Arnaud, P., A general method for fractiona-tion of plasma-proteins-dye ligand affinity-chromatography on immobilized cibacron blue F3GA. Biochem. J., 201, 129-136 (1982).
26. He, Q. Y., Lau, G. K., Zhou, Y., Yuen, S. T., Lin, M. C, Kung, H. F., and Chiu, H. F., Serum biomarkers of hepatitis B virus infected liver inflammation: a proteomic study. Proteomics, 3, 666-674 (2003).
27. Fournier, T., Medjoubi-N, N., and Porquet, D., Alpha-1-acid glycoprotein. Biochim. Biophys. Acta, 1482, 157-171 (2000).
28. Dube, J. Y., Paradis, G., Tetu, B., and Tremblay, R. R., Synthesis of alpha-1-acid glycoprotein by the human prostate. Prostate, 15, 251-258 (1989).
29. Kalmovarin, N., Friedrichs, W. E., O'brien, H. V., Linehan, L. A., Bowman, B. H., and Yang, F., Extrahepatic expression of plasma-protein genes during inflammation. Inflammation, 15, 369-379 (1991).
30. Darby, I. A., Hewitson, T., Jones, C, Fraenkel, M. B., and Becker, G., Vascular expression of clusterin in experimental cyclosporine nephrotoxicity. Exp. NephroL, 3, 234-239 (1995).
31. Eti, S., Cheng, C. Y., Marshall, A., and Reidenberg, M. M., Urinary clusterin in chronic neprotoxicity in the rat. Proc. Soc. Exp. Biol. Med., 202, 487-490 (1993).
32. Rosenberg, M. E., and Silkensen, J., Clusterin and the kidney. Exp. NephroL, 3, 9-14 (1995).
33. Girton, R. A., Sundin, D. P., and Rosenberg, M. E., Clusterin protects renal epithelial cells from gentamicin-mediated cyto-toxicity. Am. J. Physiol. Renal PhysioL, 282, F703-F709 (2002).
34. Silkensen, J. R., Agarwal, A., Nath, K. A., Manivel, J. C, and Rosenberg, M. E., Temporal induction of clusterin in cisplatin nephrotoxicity. J. Am. Soc. NephroL, 8, 302-305 (1997).
35. Fritz, I. B., and Murphy, B., Clusterin: insights into a multifunctional protein. Trends Endocrinol. Metab., 4, 41-45 (1993).
36. Rosenberg, M. E., and Silkensen, J., Clusterin: physiologic and pathophysiologic considerations. Int. J. Biochem. Cell Biol., 27, 633-645 (1995).
37. Fish, E. M., and Molitoris, B. A., Alterations in epithelial polarity and the pathogenesis of disease states. N. Engl. J. Med., 330, 1580-1588 (1994).
38. Weinberg, J. M., The cell biology of ischemic renal injury. Kidney Int., 39, 476-500 (1991).
39. Humphreys, D. T., Carver, J. A., Easterbrook-Smith, S. B., and Wilson, M. R., Clusterin has chaperone-like activity similar to that of small heat-shock proteins. J. Biol. Chem., 274, 6875-6881 (1999).
40. Poon, S., Easterbrook-Smith, S. B., Rybchyn, M. S., Carver, J. A., and Wilson, M. R., Clusterin is an ATP-independent chaperone with very broad substrate specificity that stabilizes stressed proteins in a folding-competent state. Biochemistry, 39, 15953-15960 (2000).
41. Correa-Rotter, R., Ibarra-Rubio, M. E., Schwochau, G., Cruz, C, Silkensen, J. R., Pedraza-Chaverri, J., Chmielewski, D., and Rosenberg, M. E., Induction of clusterin in tubules of nephritic rats. J. Am. Soc. NephroL, 9, 33-37 (1998).
42. Bowman, B. H., Haptoglobin. In "Hepatic Plasma Proteins," Academic Press, San Diego, pp. 120-123 (1993).
43. Tietz, N. W., "Clinical Guide to Laboratory Tests" 3rd ed., WB Saunders, Philadelphia, pp. 306-309 (1995).
44. Thomas, L., Haptoglobin/Hamopexin. In "Labor und Diagnose" 4th ed., Marburg, Medizinische Verlag, pp. 813-820 (1992).
45. Hagar, H. H., The protective effect taurine against cyclosporine A-induced oxidative stress and hepatotoxicity in rats. Toxicol. Lett, 151, 335-343 (2004).